Services / Cancer Care / Research / Clinical Trials /

Clinical Trial

« Back to List

LYM 74

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: August 01, 2011

Status: OPEN - IST
Research Hotline: 803-461-3708

Details: A Phase III, Multicenter, Randomized Trial Comparing the Efficacy of GA101 in Combination with CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL). 

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share